ALDH16A1 and hyperuricemia: The hypothesis that ALDH16A1 interacts with hypoxanthine-guanine phosphoribosyltransferase (HPRT1), which is implicated in the metabolism of uric acid and gout, was supported by the fact that the carriers of the variant present hyperuricemia.